ATE312917T1 - Familie von immunregulatoren mit der bezeichnung 'leukozyten-immunoglobulin-ähnliche rezeptoren' (lir) - Google Patents

Familie von immunregulatoren mit der bezeichnung 'leukozyten-immunoglobulin-ähnliche rezeptoren' (lir)

Info

Publication number
ATE312917T1
ATE312917T1 AT00928985T AT00928985T ATE312917T1 AT E312917 T1 ATE312917 T1 AT E312917T1 AT 00928985 T AT00928985 T AT 00928985T AT 00928985 T AT00928985 T AT 00928985T AT E312917 T1 ATE312917 T1 AT E312917T1
Authority
AT
Austria
Prior art keywords
lir
family
polypeptides
receptors
leukocyte immunoglobulin
Prior art date
Application number
AT00928985T
Other languages
English (en)
Inventor
David J Cosman
Dirk M Anderson
Luis Borges
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE312917T1 publication Critical patent/ATE312917T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00928985T 1999-05-12 2000-05-12 Familie von immunregulatoren mit der bezeichnung 'leukozyten-immunoglobulin-ähnliche rezeptoren' (lir) ATE312917T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/310,463 US6384203B1 (en) 1999-05-12 1999-05-12 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
PCT/US2000/013228 WO2000068383A2 (en) 1999-05-12 2000-05-12 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)

Publications (1)

Publication Number Publication Date
ATE312917T1 true ATE312917T1 (de) 2005-12-15

Family

ID=23202628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00928985T ATE312917T1 (de) 1999-05-12 2000-05-12 Familie von immunregulatoren mit der bezeichnung 'leukozyten-immunoglobulin-ähnliche rezeptoren' (lir)

Country Status (11)

Country Link
US (4) US6384203B1 (de)
EP (3) EP1199362A3 (de)
JP (1) JP2002543787A (de)
AT (1) ATE312917T1 (de)
AU (1) AU4713700A (de)
CA (1) CA2371193A1 (de)
CY (1) CY1105687T1 (de)
DE (1) DE60024808T2 (de)
DK (1) DK1177292T3 (de)
ES (1) ES2254173T3 (de)
WO (1) WO2000068383A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
WO2003041650A2 (en) * 2001-11-14 2003-05-22 Immunex Corporation Modulation of lir function to treat rheumatoid arthritis
AU2002357267A1 (en) * 2001-12-14 2003-06-30 President And Fellows Of Harvard College Immune related neuronal receptors and therapeutic uses thereof
JPWO2005070964A1 (ja) * 2004-01-27 2008-01-17 株式会社医学生物学研究所 単球の単離方法
US8299016B2 (en) 2004-09-03 2012-10-30 The Trustees Of Columbia University In The City Of New York ILT3 polypeptides and uses thereof
WO2006033811A2 (en) * 2004-09-03 2006-03-30 The Trustees Of Columbia University In The City Of New York Ilt3 polypeptides and uses thereof
US20070037186A1 (en) 2005-05-20 2007-02-15 Yuqiu Jiang Thyroid fine needle aspiration molecular assay
GB0510627D0 (en) * 2005-05-25 2005-06-29 Avidex Ltd Polypeptides
US8901281B2 (en) * 2005-06-17 2014-12-02 Merck Sharp & Dohme Corp. ILT3 binding molecules and uses therefor
SI1912675T1 (sl) 2005-07-25 2014-07-31 Emergent Product Development Seattle, Llc zmanjšanje števila celic B z uporabo molekul, ki se specifično vežejo na CD37 in CD20
CA2654317A1 (en) 2006-06-12 2007-12-21 Trubion Pharmaceuticals, Inc. Single-chain multivalent binding proteins with effector function
EP2041180B8 (de) * 2006-06-19 2014-03-05 Liquidating Trust Ilt3-bindende moleküle und verwendungen davon
GB0623539D0 (en) * 2006-11-24 2007-01-03 Avidex Ltd Polypeptides
AU2008287195A1 (en) * 2007-07-06 2009-02-19 Emergent Product Development Seattle, Llc Binding peptides having a C-terminally disposed specific binding domain
WO2009060159A1 (en) * 2007-11-08 2009-05-14 Medigene Limited Mutated ilt molecules
PT2132228E (pt) * 2008-04-11 2011-10-11 Emergent Product Dev Seattle Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional
WO2011091181A1 (en) 2010-01-20 2011-07-28 Tolerx, Inc. Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments
WO2011091177A1 (en) 2010-01-20 2011-07-28 Tolerx, Inc. Anti-ilt5 antibodies and ilt5-binding antibody fragments
US9696312B2 (en) 2011-09-02 2017-07-04 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand
WO2016065245A1 (en) 2014-10-24 2016-04-28 Incept, Llc Extra luminal scaffold
US10316094B2 (en) 2014-10-24 2019-06-11 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
EP3325006A4 (de) 2015-07-17 2019-03-06 The Trustees of Columbia University in the City of New York Verfahren zur behandlung von cd166-exprimierendem krebs
EP3352760A4 (de) 2015-09-21 2019-03-06 Aptevo Research and Development LLC Cd3-bindende polypeptide
KR20200103706A (ko) 2017-12-22 2020-09-02 조운스 테라퓨틱스, 인크. Lilrb2에 대한 항체
TW202428604A (zh) 2018-07-09 2024-07-16 美商戊瑞治療有限公司 結合至ilt4的抗體
AU2021265801A1 (en) 2020-05-01 2022-11-17 Ngm Biopharmaceuticals, Inc. ILt-binding agents and methods of use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4411993A (en) 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
CA1188246A (en) 1981-08-31 1985-06-04 Jerry L. Gregory Immobilized microbe recycle apparatus
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5391485A (en) 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5011912A (en) 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1990010448A2 (en) 1989-03-07 1990-09-20 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
EP0471796A4 (en) 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
US5073627A (en) 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
EP0498843B1 (de) 1989-10-24 1996-06-12 Gilead Sciences, Inc. Oligonukleotidanaloga mit neuartigen bindungen
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5262522A (en) 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
PT672141E (pt) 1992-10-23 2003-09-30 Immunex Corp Metodos de preparacao de proteinas oligomericas soluveis
US5457035A (en) 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5516658A (en) 1993-08-20 1996-05-14 Immunex Corporation DNA encoding cytokines that bind the cell surface receptor hek
US6140078A (en) * 1996-09-05 2000-10-31 Unilever Patent Holdings Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
AU4410397A (en) 1996-09-06 1998-03-26 Brigham And Women's Hospital Inhibition of mast cell activation by gp49-based mechanisms and reagents
ATE456656T1 (de) 1996-12-06 2010-02-15 Schering Corp Isolierte gene aus säuger monozyten und betreffende reagentien
WO1998031806A2 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Fc RECEPTORS AND POLYPEPTIDES
US6448035B1 (en) * 1997-04-24 2002-09-10 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)

Also Published As

Publication number Publication date
DE60024808D1 (de) 2006-01-19
DE60024808T2 (de) 2006-10-05
US6384203B1 (en) 2002-05-07
US20100080801A1 (en) 2010-04-01
EP1177292B8 (de) 2006-05-17
US20030060614A1 (en) 2003-03-27
WO2000068383A2 (en) 2000-11-16
EP1772515A1 (de) 2007-04-11
DK1177292T3 (da) 2006-05-01
JP2002543787A (ja) 2002-12-24
ES2254173T3 (es) 2006-06-16
US7875703B2 (en) 2011-01-25
CY1105687T1 (el) 2010-12-22
EP1199362A2 (de) 2002-04-24
EP1177292A2 (de) 2002-02-06
US20030027358A1 (en) 2003-02-06
EP1177292B1 (de) 2005-12-14
AU4713700A (en) 2000-11-21
CA2371193A1 (en) 2000-11-16
WO2000068383A3 (en) 2001-01-18
EP1199362A3 (de) 2002-07-17

Similar Documents

Publication Publication Date Title
ATE312917T1 (de) Familie von immunregulatoren mit der bezeichnung 'leukozyten-immunoglobulin-ähnliche rezeptoren' (lir)
TR200103297T2 (tr) Nöral ve renal gelişmenin uyarılması için Ret ligandı (RetL)
DE59109221D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
DK368588A (da) Bindingsmolekyler med en enkelt polypeptidkaede
ATE366747T1 (de) Menschliche monoklonale antikörper gegen den epidermalen wachstumsfaktorrezeptor
KR910700350A (ko) Il-2수용체의 p_55 tac 단백질에 대해 특이적인 키메릭 면역글로블린
ATE269902T1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
DE3889927D1 (de) Kennzeichnung und nachweis von mit autoimmunkrankheiten assoziierten sequenzen.
PT93345A (pt) Processo para a preparacao de moleculas de adn recombinante que codificam para receptores de interleuquina 2, de proteinas codificadas por este adn, de anticorpos monoclonais contra estas proteinas e de organismos hospedeiros transformados por este adn
ATE362941T1 (de) Identifikation, reinigung und verwendungen von leczymen und karbohydratliganden
ATE271603T1 (de) Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden
Palfree et al. N-terminal and cDNA characterization of murine lymphocyte antigen Ly-6C. 2.
DE60045681D1 (de) Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
RU2002133470A (ru) Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы
WO1996021020A3 (en) Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
ATE35427T1 (de) Rekombinante dna, damit transformierter mikroorganismus und dessen verwendung.
EP1270588A4 (de) NEUESKOLLAGEN-äHNLICHES PROTEIN CLAC, DESSEN VORLäUFER UND DAFüR KODIERENDE GENE
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
NO921219D0 (no) Somatostatin reseptor
DE69330966D1 (de) DNA-Sequenzen des Epstein-Barr Virus kodierend für ein diagnostisch relevantes Virus-Hüllprotein, durch PCR erhaltene Expressionsklone und Verwendung dieses rekombinanten Antigens in diagnostischen Tests
Bannon et al. Localization of neurokinin receptor gene expression in the developing and adult rat brain
WO2000049144A3 (en) Pyk2 binding proteins
ATE332308T1 (de) Sekretiertes und transmembranes polypeptid und dafür kodierende nukleinsäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1177292

Country of ref document: EP

REN Ceased due to non-payment of the annual fee